In addition, IDO and TDO may activate depression through the metabolite 3-hydroxy-kynerunine (3OH-KYN) and quinolinic acid (QUIN) (Heyes et al., 1996; Guillemin et al., 2005). The gene discussed is TDO2; the disease is depressive symptom measurement.